Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Bessereau

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|November 20, 2012
Adherence to protocol and determinants in ST-elevation myocardial infarctionNathalie Fournier, Jacques Bessereau, Anne Champenois, et al.
Thrombosis Research|January 31, 2012
Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockadeLaurent Bonello, Laurence Camoin-Jau, Julien Mancini, et al.
Presse Medicale (Paris, France : 1983)|January 22, 2011
[Pandemic influenza A (H1N1 virus) on Futuna Island in the Pacific, from August to September 2009]Hichem Chenaitia, Horace Massa, Philippe Garry, et al.
Toxicology and Industrial Health|May 5, 2018
Response to: Carbon monoxide poisoning cases presenting with non-specific symptoms by Deniz. Accuracy of triage with RAD-57 pulse CO-oximeter in suspected collective intoxication of a pediatric populationJacques Bessereau, F Heireche, V Bremond, et al.
Expert Review of Cardiovascular Therapy|September 3, 2013
Assessing post-treatment platelet reactivity: a focus on patient selection and settingMarc Laine, Corinne Frere, Olivia Ronsin, et al.
International Journal of Cardiology|March 12, 2014
Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patientsMelanie Gaubert, Marc Laine, Toesca Richard, et al.
Thrombosis and Haemostasis|April 27, 2012
Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarctionLaurent Bonello, Julie Berbis, Marc Laine, et al.
International Journal of Cardiology|July 23, 2013
Ticagrelor or prasugrel for pre-hospital protocols in STEMI?Nathalie Fournier, Richard Toesca, Jacques Bessereau, et al.
Thrombosis and Haemostasis|October 25, 2013
Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised studyMarc Laine, Corinne Frère, Richard Toesca, et al.
International Journal of Cardiology|August 6, 2013
A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivityLaurent Bonello, Marc Laine, Karine Baumstarck, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|November 20, 2012
Adherence to protocol and determinants in ST-elevation myocardial infarctionNathalie Fournier, Jacques Bessereau, Anne Champenois, et al.
Thrombosis Research|January 31, 2012
Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockadeLaurent Bonello, Laurence Camoin-Jau, Julien Mancini, et al.
Presse Medicale (Paris, France : 1983)|January 22, 2011
[Pandemic influenza A (H1N1 virus) on Futuna Island in the Pacific, from August to September 2009]Hichem Chenaitia, Horace Massa, Philippe Garry, et al.
Toxicology and Industrial Health|May 5, 2018
Response to: Carbon monoxide poisoning cases presenting with non-specific symptoms by Deniz. Accuracy of triage with RAD-57 pulse CO-oximeter in suspected collective intoxication of a pediatric populationJacques Bessereau, F Heireche, V Bremond, et al.
Expert Review of Cardiovascular Therapy|September 3, 2013
Assessing post-treatment platelet reactivity: a focus on patient selection and settingMarc Laine, Corinne Frere, Olivia Ronsin, et al.
International Journal of Cardiology|March 12, 2014
Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patientsMelanie Gaubert, Marc Laine, Toesca Richard, et al.
Thrombosis and Haemostasis|April 27, 2012
Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarctionLaurent Bonello, Julie Berbis, Marc Laine, et al.
International Journal of Cardiology|July 23, 2013
Ticagrelor or prasugrel for pre-hospital protocols in STEMI?Nathalie Fournier, Richard Toesca, Jacques Bessereau, et al.
Thrombosis and Haemostasis|October 25, 2013
Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised studyMarc Laine, Corinne Frère, Richard Toesca, et al.
International Journal of Cardiology|August 6, 2013
A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivityLaurent Bonello, Marc Laine, Karine Baumstarck, et al.
Pageof 4